Cargando…
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands
PURPOSE: During the SARS-CoV-2 pandemic, national and international societies have recommended continuing biological agents in patients with immune-mediated inflammatory diseases (IMID) in the absence of SARS-CoV-2 symptoms. However, adherence to biological treatment might decrease, because these re...
Autores principales: | van der Groef, Romy, de Jong, Pascal H P, Hijnen, Dirk Jan, van der Woude, Christien J, van Laar, Jan A M, van der Kuy, P Hugo M, Brugma, Jan-Dietert, Pasma, Annelieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869789/ https://www.ncbi.nlm.nih.gov/pubmed/36698858 http://dx.doi.org/10.2147/PPA.S392290 |
Ejemplares similares
-
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry
por: Looijen, Agnes E M, et al.
Publicado: (2023) -
Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains
por: van der Vossen, Anna, et al.
Publicado: (2021) -
Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices
por: Dane, Aniek, et al.
Publicado: (2023) -
How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrument
por: Pasma, Annelieke, et al.
Publicado: (2014) -
Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease
por: Paulides, Emma, et al.
Publicado: (2021)